Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway

Breast cancer chemoresistance hampers chemotherapy efficacy; researchers investigate the pharmacological activities of natural products for potential solutions. This study aimed to determine the effect of morin, a bioflavonoid isolated from Maclura pomifera, on two Dox-resistant human breast cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioFactors (Oxford) 2024-08
Hauptverfasser: Maharjan, Sushma, Lee, Min-Gu, Lee, Kyu-Shik, Nam, Kyung-Soo
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title BioFactors (Oxford)
container_volume
creator Maharjan, Sushma
Lee, Min-Gu
Lee, Kyu-Shik
Nam, Kyung-Soo
description Breast cancer chemoresistance hampers chemotherapy efficacy; researchers investigate the pharmacological activities of natural products for potential solutions. This study aimed to determine the effect of morin, a bioflavonoid isolated from Maclura pomifera, on two Dox-resistant human breast cancer cell lines MDA-MB-231 (MDA-DR) and MCF-7 (MCF-DR). Sulforhodamine B and colony-forming assays demonstrated the cytotoxic effect of morin on both cell lines. Morin induced DNA damage and reduced the DNA repair mechanism, a feature of chemoresistance. In addition, morin reduced the protein expressions of cell cycle regulators, such as cyclin D1, CDK4, cyclin E1, cyclin B1, and p-Rb, thereby halting cell cycle progression. Moreover, morin slightly reduced PARP and Bcl-xL expressions but left LC3-II and RIPK3 expressions unchanged. Annexin-V/7-AAD analysis showed morin increased 7-AAD positive cells and annexin-V positive cells among MDA-DR and MCF-DR cells, respectively. In addition, morin increased p-AMPK and p-LKB1 levels; and, thus, inhibited phosphorylation of the mTOR pathway, but decreased t-AMPK levels by inducing lysosomal degradation, and AICAR, an AMPK activator, reduced Raptor, cyclin D1, CDK4, cyclin E1 and phosphorylated, and total mTOR levels, indicating AMPK is a key player in inducing cell death. Also, morin modulated MAPK phosphorylation and attenuated p-Akt and p-GSK3αβ levels; and thus, inhibited cell survival. In addition, morin suppressed tumor growth in our MDA-DR xenografted mouse model. These findings indicate that morin is a potential treatment for Dox-resistant breast cancer and that it does so by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 pathway, along with regulating the MAPK, and Akt/GSK3αβ signaling pathways.
doi_str_mv 10.1002/biof.2112
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3090637861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3090637861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c175t-4882cb2719ca4698a8f63bc67aab9cbb8a8fb2464f5edc25c084c23a2cce7d2a3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EoqWw4AeQl7BI60fqOMtSnmpLESrraOw4bVASFzsB-gt8NYkKrEZz79FdHITOKRlSQthI5TYbMkrZAepTGbFAEkkPUZ_EYxqIkPMeOvH-jRDKSSiPUY_HlIax4H30vbAur7D9ME7b0nic2i_rGpXrNnXG576GShvcfpumhAorZ8DXWHepw2rXNmnTwmt88zTBKZSwNhiqFJc2bQqou6beGDyfXdPRZPE8G5Wr5cuUYp-vKyi6egv15hN2p-gog8Kbs987QK93t6vpQzBf3j9OJ_NA02hcB6GUTCsW0VhDKGIJMhNcaREBqFgr1QWKhSLMxibVbKyJDDXjwLQ2UcqAD9Dlfnfr7HtjfJ2UudemKKAytvEJJzERPJKCtujVHtXOeu9MlmxdXoLbJZQknfqkU5906lv24ne2UaVJ_8k_1_wHiUyAuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090637861</pqid></control><display><type>article</type><title>Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway</title><source>Wiley Blackwell Single Titles</source><creator>Maharjan, Sushma ; Lee, Min-Gu ; Lee, Kyu-Shik ; Nam, Kyung-Soo</creator><creatorcontrib>Maharjan, Sushma ; Lee, Min-Gu ; Lee, Kyu-Shik ; Nam, Kyung-Soo</creatorcontrib><description>Breast cancer chemoresistance hampers chemotherapy efficacy; researchers investigate the pharmacological activities of natural products for potential solutions. This study aimed to determine the effect of morin, a bioflavonoid isolated from Maclura pomifera, on two Dox-resistant human breast cancer cell lines MDA-MB-231 (MDA-DR) and MCF-7 (MCF-DR). Sulforhodamine B and colony-forming assays demonstrated the cytotoxic effect of morin on both cell lines. Morin induced DNA damage and reduced the DNA repair mechanism, a feature of chemoresistance. In addition, morin reduced the protein expressions of cell cycle regulators, such as cyclin D1, CDK4, cyclin E1, cyclin B1, and p-Rb, thereby halting cell cycle progression. Moreover, morin slightly reduced PARP and Bcl-xL expressions but left LC3-II and RIPK3 expressions unchanged. Annexin-V/7-AAD analysis showed morin increased 7-AAD positive cells and annexin-V positive cells among MDA-DR and MCF-DR cells, respectively. In addition, morin increased p-AMPK and p-LKB1 levels; and, thus, inhibited phosphorylation of the mTOR pathway, but decreased t-AMPK levels by inducing lysosomal degradation, and AICAR, an AMPK activator, reduced Raptor, cyclin D1, CDK4, cyclin E1 and phosphorylated, and total mTOR levels, indicating AMPK is a key player in inducing cell death. Also, morin modulated MAPK phosphorylation and attenuated p-Akt and p-GSK3αβ levels; and thus, inhibited cell survival. In addition, morin suppressed tumor growth in our MDA-DR xenografted mouse model. These findings indicate that morin is a potential treatment for Dox-resistant breast cancer and that it does so by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 pathway, along with regulating the MAPK, and Akt/GSK3αβ signaling pathways.</description><identifier>ISSN: 0951-6433</identifier><identifier>ISSN: 1872-8081</identifier><identifier>EISSN: 1872-8081</identifier><identifier>DOI: 10.1002/biof.2112</identifier><identifier>PMID: 39114963</identifier><language>eng</language><publisher>Netherlands</publisher><ispartof>BioFactors (Oxford), 2024-08</ispartof><rights>2024 International Union of Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c175t-4882cb2719ca4698a8f63bc67aab9cbb8a8fb2464f5edc25c084c23a2cce7d2a3</cites><orcidid>0000-0003-3781-3171 ; 0000-0001-7111-1830</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39114963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maharjan, Sushma</creatorcontrib><creatorcontrib>Lee, Min-Gu</creatorcontrib><creatorcontrib>Lee, Kyu-Shik</creatorcontrib><creatorcontrib>Nam, Kyung-Soo</creatorcontrib><title>Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway</title><title>BioFactors (Oxford)</title><addtitle>Biofactors</addtitle><description>Breast cancer chemoresistance hampers chemotherapy efficacy; researchers investigate the pharmacological activities of natural products for potential solutions. This study aimed to determine the effect of morin, a bioflavonoid isolated from Maclura pomifera, on two Dox-resistant human breast cancer cell lines MDA-MB-231 (MDA-DR) and MCF-7 (MCF-DR). Sulforhodamine B and colony-forming assays demonstrated the cytotoxic effect of morin on both cell lines. Morin induced DNA damage and reduced the DNA repair mechanism, a feature of chemoresistance. In addition, morin reduced the protein expressions of cell cycle regulators, such as cyclin D1, CDK4, cyclin E1, cyclin B1, and p-Rb, thereby halting cell cycle progression. Moreover, morin slightly reduced PARP and Bcl-xL expressions but left LC3-II and RIPK3 expressions unchanged. Annexin-V/7-AAD analysis showed morin increased 7-AAD positive cells and annexin-V positive cells among MDA-DR and MCF-DR cells, respectively. In addition, morin increased p-AMPK and p-LKB1 levels; and, thus, inhibited phosphorylation of the mTOR pathway, but decreased t-AMPK levels by inducing lysosomal degradation, and AICAR, an AMPK activator, reduced Raptor, cyclin D1, CDK4, cyclin E1 and phosphorylated, and total mTOR levels, indicating AMPK is a key player in inducing cell death. Also, morin modulated MAPK phosphorylation and attenuated p-Akt and p-GSK3αβ levels; and thus, inhibited cell survival. In addition, morin suppressed tumor growth in our MDA-DR xenografted mouse model. These findings indicate that morin is a potential treatment for Dox-resistant breast cancer and that it does so by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 pathway, along with regulating the MAPK, and Akt/GSK3αβ signaling pathways.</description><issn>0951-6433</issn><issn>1872-8081</issn><issn>1872-8081</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRS0EoqWw4AeQl7BI60fqOMtSnmpLESrraOw4bVASFzsB-gt8NYkKrEZz79FdHITOKRlSQthI5TYbMkrZAepTGbFAEkkPUZ_EYxqIkPMeOvH-jRDKSSiPUY_HlIax4H30vbAur7D9ME7b0nic2i_rGpXrNnXG576GShvcfpumhAorZ8DXWHepw2rXNmnTwmt88zTBKZSwNhiqFJc2bQqou6beGDyfXdPRZPE8G5Wr5cuUYp-vKyi6egv15hN2p-gog8Kbs987QK93t6vpQzBf3j9OJ_NA02hcB6GUTCsW0VhDKGIJMhNcaREBqFgr1QWKhSLMxibVbKyJDDXjwLQ2UcqAD9Dlfnfr7HtjfJ2UudemKKAytvEJJzERPJKCtujVHtXOeu9MlmxdXoLbJZQknfqkU5906lv24ne2UaVJ_8k_1_wHiUyAuA</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>Maharjan, Sushma</creator><creator>Lee, Min-Gu</creator><creator>Lee, Kyu-Shik</creator><creator>Nam, Kyung-Soo</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3781-3171</orcidid><orcidid>https://orcid.org/0000-0001-7111-1830</orcidid></search><sort><creationdate>20240808</creationdate><title>Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway</title><author>Maharjan, Sushma ; Lee, Min-Gu ; Lee, Kyu-Shik ; Nam, Kyung-Soo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c175t-4882cb2719ca4698a8f63bc67aab9cbb8a8fb2464f5edc25c084c23a2cce7d2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maharjan, Sushma</creatorcontrib><creatorcontrib>Lee, Min-Gu</creatorcontrib><creatorcontrib>Lee, Kyu-Shik</creatorcontrib><creatorcontrib>Nam, Kyung-Soo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>BioFactors (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maharjan, Sushma</au><au>Lee, Min-Gu</au><au>Lee, Kyu-Shik</au><au>Nam, Kyung-Soo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway</atitle><jtitle>BioFactors (Oxford)</jtitle><addtitle>Biofactors</addtitle><date>2024-08-08</date><risdate>2024</risdate><issn>0951-6433</issn><issn>1872-8081</issn><eissn>1872-8081</eissn><abstract>Breast cancer chemoresistance hampers chemotherapy efficacy; researchers investigate the pharmacological activities of natural products for potential solutions. This study aimed to determine the effect of morin, a bioflavonoid isolated from Maclura pomifera, on two Dox-resistant human breast cancer cell lines MDA-MB-231 (MDA-DR) and MCF-7 (MCF-DR). Sulforhodamine B and colony-forming assays demonstrated the cytotoxic effect of morin on both cell lines. Morin induced DNA damage and reduced the DNA repair mechanism, a feature of chemoresistance. In addition, morin reduced the protein expressions of cell cycle regulators, such as cyclin D1, CDK4, cyclin E1, cyclin B1, and p-Rb, thereby halting cell cycle progression. Moreover, morin slightly reduced PARP and Bcl-xL expressions but left LC3-II and RIPK3 expressions unchanged. Annexin-V/7-AAD analysis showed morin increased 7-AAD positive cells and annexin-V positive cells among MDA-DR and MCF-DR cells, respectively. In addition, morin increased p-AMPK and p-LKB1 levels; and, thus, inhibited phosphorylation of the mTOR pathway, but decreased t-AMPK levels by inducing lysosomal degradation, and AICAR, an AMPK activator, reduced Raptor, cyclin D1, CDK4, cyclin E1 and phosphorylated, and total mTOR levels, indicating AMPK is a key player in inducing cell death. Also, morin modulated MAPK phosphorylation and attenuated p-Akt and p-GSK3αβ levels; and thus, inhibited cell survival. In addition, morin suppressed tumor growth in our MDA-DR xenografted mouse model. These findings indicate that morin is a potential treatment for Dox-resistant breast cancer and that it does so by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 pathway, along with regulating the MAPK, and Akt/GSK3αβ signaling pathways.</abstract><cop>Netherlands</cop><pmid>39114963</pmid><doi>10.1002/biof.2112</doi><orcidid>https://orcid.org/0000-0003-3781-3171</orcidid><orcidid>https://orcid.org/0000-0001-7111-1830</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0951-6433
ispartof BioFactors (Oxford), 2024-08
issn 0951-6433
1872-8081
1872-8081
language eng
recordid cdi_proquest_miscellaneous_3090637861
source Wiley Blackwell Single Titles
title Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T15%3A46%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morin%20overcomes%20doxorubicin%20resistance%20in%20human%20breast%20cancer%20by%20inducing%20DNA%20damage%20and%20modulating%20the%20LKB1/AMPK/mTORC1%20signaling%20pathway&rft.jtitle=BioFactors%20(Oxford)&rft.au=Maharjan,%20Sushma&rft.date=2024-08-08&rft.issn=0951-6433&rft.eissn=1872-8081&rft_id=info:doi/10.1002/biof.2112&rft_dat=%3Cproquest_cross%3E3090637861%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3090637861&rft_id=info:pmid/39114963&rfr_iscdi=true